| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue | 90 | 113 | 115 | 92 |
| Cost of Revenue | 8 | 26 | 37 | (61) |
|
| Gross Profit | 83 | 87 | 78 | 153 |
|
| Operating Expenses |
| Research Development | 3 | 4 | 13 | 17 |
| Selling General and Administrative | 140 | 135 | 137 | 145 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others | 23 | 22 | 22 | 20 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (82) | (75) | (94) | (29) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 11 | (6) | 9 | 26 |
| Earnings Before Interest And Taxes | (245) | (81) | (85) | (3) |
| Interest Expense | (116) | 58 | 58 | 59 |
| Income Before Tax | (129) | (139) | (143) | (63) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (129) | (139) | (143) | (63) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (129) | (139) | (143) | (63) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($129) | ($139) | ($143) | ($63) |
0.51% Nasdaq 
Income Statement
